rt.” ‘m' A. “ham“ h” __. 'x'f “J LIBRARY Michigan S tau: University tween This is to certify that the thesis entitled Enzyme-Mediated Synthesis of the Antigenic Portion of the Blood Group 0 Substance with Specific Carbon-13 Enrichment presented by Paul R. Rosevear has been accepted towards fulfillment of the requirements for Ph- D- degree in _B.iochemj_s.try Major professor [Mme May 12, 1980 0-7639 .D ‘ l‘ b ‘1. “L\ ’“‘€:‘\ k . V .4 (in :‘glm'r V » 1" w: 25¢ per day per item RETURNING LIBRARY MATERIALS: M Place in book return to remove charge from circulation records ENZYME-MEDIATED SYNTHESIS OF THE ANTIGENIC PORTION OF THE BLOOD GROUP 0 SUBSTANCE WITH SPECIFIC CARBON-13 ENRICHMENT By Paul Richard Rosevear A DISSERTATION Submitted to Michigan State University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Department of Biochemistry kin m 95 ABSTRACT ENZYME-MEDIATED SYNTHESIS OF THE ANTIGENIC PORTION OF THE BLOOD GROUP 0 SUBSTANCE WITH SPECIFIC CARBON-13 ENRICHMENT. By Paul Richard Rosevear The use of partially purified glycosyltranferases and chemically synthesized sugar nucleotides provides an alternative method for synthesis of complex carbohydrates. Enzymatic synthesis of the glycosidic linkage has been shown to proceed with anomeric specificity, and high yield. This approach was used in the synthesis of mmole quantities of the anitgenic portion of the blood group 0 substance with specific carbon-13 enrichment. Partially purified bovine Nfacetylglucosaminide B (1-4) galactosyltransferase and porcine 8 galactoside a(1-2) fucosyltransferase were used with chemically synthesized sugar nucleotides in the synthesis of the antigenic trisaccharide Fuc a(1-2)GalB(1-4)GlcNAc-B-hexanolamine. The B-galactoside a(1-2) fucosyltransferase was partially purified from porcine submaxillary glands by a procedure similar to T.A. Beyer and R.L. Hill (unpublished results). The purification entailed; solubilization with Triton X-100, chromatography on the affinity adsorbant GDP-Sepharose, Sephadex GSO chromatography and concentration on GDP-Sepharose. The enzyme was purified 11,000 fold and was used in the synthesis of mmole quantities of several fucosylated di and trisaccharides. The enzyme-mediated synthesis of fucosylated oligosaccharides was performed by adding equimolar ratios of GDP-fucose and acceptor to the enzyme in sodium cacodylate buffer, pH 6.0 in the presence of manganese chloride at 33°. After 12 hours of incubation, yields of the fucosyla- ted compounds were typically 80%. The remaining GDP-fucose was hydrolyzed to fucose during the incubation. Purification of the product di or trisaccharide was rapidly achieved by deproteinization, ion exchange chromatography and gel filtration. Enzymatic synthesis with Specifically enriched UDP-[1-13CJ-D-Galactose, GDP-[1-13CJ-L-fu- cose or 13C-enriched acceptors allowed preparation of singly or doubly enriched di and trisaccharides. Specific 13C-enrichment and comparison with 13C-enriched model compounds allowed unambiguous resonance assignments of the carbons in the trisaccharide using IJC—C’ ZJC-C and BJC-C coupling constants. Derivatization of a carbon with another aldopyranosyl ring resulted in a 5-8 ppm downfield shift of that resonance. Carbons contiguous to the derivatized carbon also underwent small chemical shift changes. The B-galactoside a(1-2) fucosyltransferase was unambiguously shown to transfer fucose from GDP-L-fucose to C2 galactose when [1-13C]Gals(1-4)GlcNAc-B-hexanolamine was used as the acceptor. The CZ galactose was easily identified by a 'JCI'CZ' coupling of 46 Hz. Inter-residue 3JC-C’ 3JC-H and ZJC-C coupling constants in the singly and doubly enriched fucosylated oligosaccharides allowed estimation of the most abundant conformer for the w and 0 torsion angles in the Gals(1-4)GlcNAc and FuCa(1-2)Gal glycosidic linkages. DEDICATION The author would like to dedicate this work to his wife Cathryn Carson Rosevear for the joy that she has given me, her love, and her continual support throughout the days of research and preparation of this work, and to his mother Dorothy B. Rosevear for her love, encouragment and help throughout the years. ii ACKNOWLEDGMENTS The author would like to thank his thesis advisor, Dr. Robert Barker, for the Opportunity to work in his laboratory and financial support. Special thanks are necessary for Dr. Shelagh Ferguson-Miller, Dr. John Wang, and Dr. Hernan Nunez for their friendship, advice, valuable discussions during the course of this research, and colaborations. The author also wishes to thank the Department of Biochemistry, Michigan State University, for it's generous support during the final stages of this work. Special thanks to the Purdue University Biochemical Magnetic Resonance Laboratory, Dr. A.S. Mildvan for the use of the Bruker-ZSO MHz NMR at the Institute for Cancer Research and the Stable Isotopes Resource of the Los Alamos National Laboratory. TABLE OF CONTENTS LIST OF TABLES LIST OF FIGURES ABBREVIATIONS INTRODUCTION REVIEW OF THE LITERATURE Current Concepts in Glycoprotein Biosynthesis The Biochemical Structure and Synthesis of the Blood Group Substances Review of the Purification and Properties of Lactose Synthetase Review of the Literature on the Fucosyltransfease Review of 13C-NMR Spectrosc0py and 13C-13C Spin- Spin Coupling Constants METHODS Materials Analytical Procedures Thin Layer Chromatography High Voltage Electrophoresis High Pressure Liquid Chromatography Gas Chromatography Radioactivity Measurements Carbon-13 NMR Spectroscopy Quantitation of Hexanolamine Compounds iv Page vii viii xi 10 14 17 22 28 28 28 28 29 29 29 29 3O 30 Protein Determination Synthetic Procedures GMP-Morpholidate and UMP-Morpholidate 6-Amino-1-Hexanol PhOSphate N-Trifluoroacetyl 6-Amino-1-Hexanol Phosphate P'-(6-Amino-1-Hexyl)-P-(5'-Guanosine)-Pyrophosphate P'-(6-Amino-1-Hexyl)-P-(5'-Uridine)-Pyrophosphate GDP-Hexanolamine Sepharose UDP-Hexanolamine Sepharose UDP-s-D-Galactose GDP-a-L-Fucose 2-Acetamido-3,4,6-tri-ancetyl-2-deoxy-Glucopyranosyl Chloride NfTriflouroacetyl-6-Amino-1-Hexyl-2-Acetamido-2-Deoxy-B- D-Glucopyranoside 6-Amino-1-Hexyl-2-Acetamido-2-Deoxy-e-D-Glucopyranoside Acetobromogalactose 6-Amino-1-Hexyl-a,3-D-Galactopyranoside Ethyl-e-D-Galactopyranoside 5-Deoxy-L-Lyxose [1-13c, 6-3H]-L-Fucose and [1-13c, 6-3HJ-6-Deoxy- L-Talose [1-13CJ-D-Galactose [2-13CJ-D-Galactose Purification of Bovine UDP-GalactosezGlucose-B-(1-4) Galactosyltransferase page 30 3O 30 31 31 31 32 33 33 33 35 35 36 36 36 37 38 38 4o 41 41 41 page Preparation of Galactosylated Disaccharides 42 Purification of Galactosylated Disaccharides 42 Assay of Porcine B-Galactoside a(1-2)Fucosyltranferase 42 Purification of a Porcine B-Galactoside a(1-2) 44 Fucosyltransferase Preparation of Fucosylated Oligosaccharides 47 Purification of Enzymatically Synthesized Oligosaccharides 48 RESULTS 49 Synthesis of Galactosylated Disaccharides Enzymatic Assay of the B-Galactoside a(1-2) 49 Fucosyltransferase Purification of the Porcine B-Galactoside a(1-2) 50 Fucosyltransferase Synthesis and Purification of Fucosylated Oligosaccharides 56 Carbon-13 NMR Analysis of Fucosylated Oligosaccharides 71 Conformational Analysis of the Fucosylated Oligosaccharides 88 DISCUSSION 102 Preparation of B-Galactoside a(1-2)Fucosyltransferase 102 Preparation of Fucosylated Oligosaccharides 105 Carbon-13 NMR of Fucosylated Oligosaccharides 106 Conformation of the Fucosylated Oligosaccharides 108 BIBLIOGRAPHY 128 APPENDIX 135 vi LIST OF TABLES Page 1. Purification of the Porcine Submaxillary B-Galactose a(I-2) 52 Fucosyltransferase 2. Carbon-13 Chemical Shift Assignments 74 vii 1. 3. 9. 10. LIST OF FIGURES Structures Of the Q-Glycosidically Linked Oligosaccharides. The Scheme Of Synthesis Of Type Two Blood Group Antigens, Their Participating Genes and Their Primary Products, Glycosyltransferases. Purification 0f the Porcine Submaxillary Gland B-Galactoside a(1-2) Fucosyltransferase By NaCl Elution From GDP-Sepharose. Purification and Desalting Of The B-Galactoside a(1-2)Fucosyltransferase. Concentration Of The Porcine B-Galactoside a(1-2)Fucosyltrans- ferase By GDP-Sepharose II Chromatography. The Kinetics Of Fucosylation Of GalB(1-4)GlcNAc-3-Hexanolamine Nith Porcine s-Galatoside a(1-2)Fucosyltransferase. Time Course Of Fucosylation of [1- 13C]Gale(1-4)GlcNAc Followed By High Pressure Liquid Chromatography. Kinetics Of Hydrolysis 0f GDP-Fucose By The s-Galactoside a(1-2) Fucosyltransferase In The Absence Of An Acceptor Substrate. Separation of FUCa(1-2)Gal-3-Hexanolamine and Gal-B-Hexanola- mine By Gel Filtration. . The 15.08 MHz Proton Decoupled, 13C-NMR Of; A. The Galac tosyltransferase Acceptor Substrate GlcNAc-B-Hexanolamine, B. The Galactosylated Product, Gal3(1-4)GlcNAc-3-Hexanolamine. viii Page 9 12 58 63 65 67 7O 73 11. 12. 13. 14. 15. 16. 17. 18. 19. The 15.08 MHz, Proton Decoupled, 13C-NMR 0f Gal-B-Hexanolamine. The 90 MHz, Proton Decoupled, l3C-NMR Of FUCo(1-2) GalB(1-4)GlcNAc-3-Hexanolamine. The 90 MHz, Proton Decoupled, Natural Abundance 13C-NMR Spectrum of the Antigenic Trisaccharide, FuCo(1-2)Gals(1-4)GlcNAc-B-Hexanolamine. An Expanded 90 MHz, Proton Decoupled, 133-NMR Spectrum of the Anomeric Region Of FUCa(1-2)GaIB(1-4)GTCNAC-B- Hexanolamine. The 45 MHz, Proton Decoupled, 13C-NMR Of The Trisaccharide FUCa(1-2) [1-13C]Gal3(1-4)GlcNAc-3-Hexanolamine. An Expanded Region From C2 to C6 Of The 90 MHz, Proton Decoupled, 13C-NMR or FUCa(1-2) [1-13C]Gale(1-4) GlcNAc-B-Hexanolamine. The Conformation About The Glycosidic Bond In FUCo(1-2)Gal Can Be Defined By Two Torsion (Dihedral Angles, w (Cl-O-C2'-Cl') and 0 (Hl-Cl-O-CZ'). The 90 MHz, Proton Decoupled, 13C-NMR Spectrum Of The Anomeric Region Of The Trisaccharide FUCo(1-2) [1-13C] Gal3(1-4)GlcNAc-B-Hexanolamine. Carbon-13 NMR Linewidth Measurements Of The 13C-Enriched Resonances in FuCo(1-2)[1-13C]Gals(1-4)GlcNAc-s-Hexanolamine and [1-I3CJFUCo(1-2)[1-13C]Gal3(1-4)GlcNAc-e-Hexanolamine. ix page 77 80 82 85 87 9O 93 95 98 20. 21. 22. 23. 24. page The 180 MHz 'H-NMR Showing the Hl Fuc Resonance In; A. 101 FUCo(1-2)Gal-B-Ethyl, and B. Fuc a(1-2)[2-13C]Gal-B-Ethyl. Newman Projections Describing the Two Torsional (Dihedral) 111 Angles, uyand 0, About the Glycosidic Bond In Fuc a(1-2)Gal. The Proposed ipTorsion Angle For The Glycosidic Linkage In 115 GalB(1-4)GlcNAc-3-Hexanolamine. Possible w Torsional Angles About The Fuca(1-2)Gal Glycosidic 121 Linkage. Torsional Angles About the FUCo(1-2)Gal Glycosidic Linkage 124 Expected To Give Approximately A 1.5 Hz Vicinal Coupling Between ClGal and ClFuc. ABBREVEATIONS 2,5-diphenyloxazole, PPO; 1,4 bis [2(-4-methyl-5-phenyloxazolyl)]- benzene, POPOP; parts per million, ppm; guanosine monophoshate, GMP; guanosine diphosphate, GDP; guanosine triphosphate, GTP; uridine mono- phosphate, UMP; uridine diphosphate, UDP; uridine triphosphate, UTP; hydrochloric acid, HCl; lithium chloride, LiCl; sodium hydroxide, NaOH; Nfacetylglucosamine, GlcNAc; L-fucose, Fuc; galactose, Gal; glucose , Glc; (6-amino-1-hexyl)-2-acetamido-2-deoxy-3-D-glucopyranoside, GlcNAc:B-hexanolamine; magnesium perchlorate, Mg(ClO4)2; mercuric cyanide, Hg(CN)2; tetramethylsilane, TMS; lactose, Gal8(1-4)Glc; .Neacetyllactosamine, GalB(1-4)GlcNAc; (6-amino-1-hexyl)-4gg (s-D-galactopyranosyl)-2-acetamido-2-deoxy-D-glucose; GalB(1-4)GlcNAc-B— hexanolamine; (6-amino-1-hexyl)-3-D-galactopyranoside, Gal-B-hexanola- mine; ethyl-B-D-galactopyranoside, ethyl-Gal; methyl-a-L-fucopyranoside, methyl-Fuc; (6-amino-1-hexyl)-4597(fucopyranosyla(1-2) B-D-galactopyran- osyl)-2-acetamido-2-deoxy-8-D-glucopyranoside, Fuc a(1-2)Gale(1-4) GlcNAc-B-hexanolamine; (6-amino-1-hexyl)-259io-L-fucopyranosyl)-galacto- pyranoside, Fuc a(1-2)Gal-B-hexanolamine; ZgQTo-L-fucopyranosyl)-D-gal- actOpyranose, Fuc o(1-2)Gal; 13C nuclear magnetic resonance spectro- scopy, 13C-nmr; 'H nuclear magnetic resonance spectroscopy, 'H-nmr; Sulfopropyl-Sephadex, SP-Sephadex, high pressure liquid chromatography, HPLC. xi INTRODUCTION Carbohydrates present on glycoproteins and glycolipids have recently become an active area of interest due to their probable role in cell-cell adhesion, density dependent growth inhibition, molecular recognition, hormonal control, blood clotting, immunological protection, structural support, and surface protection (1,2). Glycoproteins are ubiquitously distributed in nature, occuring in vertebrates, invertebrates, plants, bacteria and viruses. One important class of glyc0proteins and glycolipids are the ABO blood group substances. Aside from the recognized importance of the ABO antigens in blood typing and transfusion, they have been implicated in carcinoma, ulcers, pernicious anemia, hemolytic disease of the newborn, fetal loss and infertility (1,3). A versatile chemical synthesis of these kinds of complex, biologically active, oligosaccharides has not been accomplished. Lemieux and coworkers, have succeeded in the chemical synthesis of the Lewis and B blood-group antigenic determinants (4,5). However, their method was extremely laborious, involving complex blocking groups, difficult o-glycosidations, purifications, and limited in the ability to vary the aglycon at the reducing end of the carbohydrate moiety. A more versatile approach to the synthesis of biologically active oligosaccharides is needed due to the difficulty of isolation from natural sources, marked heterogenity when isolated, and limited availability. The necessity for a general method of oligosaccharide synthesis becomes increasingly important with the advent of 13C nmr spectroscopy in the elucidation of structures and conformations of 1 oligosaccharides, antigenic determinants, glycoside-protein complexes, and micelles containing gangliosides (6,7,8,9,10,11,12). Carbon-13 nmr spectroscopy, with the use of apprOpriately labeled 13C compounds, provides an excellent nondestructive tool for probing the conformations and biological interactions of this important class of compounds. One approach to this problem is the use of a combination of chemical and enzymatic methods for the synthesis of complex oligosaccharides. This approach involves the chemical synthesis of enzyme substrates, with appropriate labels when necessary, and the use of these substrates with specific enzymes for the synthesis of oligosaccharide linkages. Enzymatic synthesis of the glycosidic linkage proceeds with specificity, high yield, and relative ease as compared to the chemical methods for synthesis of these linkages (4,5,13). One example of this type of synthesis is the use of the Nfacetylglucosaminide 3(1-4) galactosyltransferase in the synthesis of Nyacetyllactosamine, glycosidic derivatives of Nyacetyllactosamine and specifically labeled [13CJ—N7acetyllactosamine (13,14,15). This type of enzymatic approach to synthesis of carbohydrates has been used as early as 1955 by Bean and Hassid for the synthesis of several disaccharides (16). However, this approach has not been used for the synthesis of branched chain complex oligosaccharides found on cell surfaces that are responsible for antigenic activity. The combination of chemical and enzymatic syntheses requires that quantities of substrate and at least partially pure enzyme preparations be available. The ABO blood group substances provide an excellent class of complex oligosaccharides to attempt a combination of chemical and enzymatic syntheses. Each carbohydrate is known to be transferred from a sugar nucleotide donor to the nascent chain by action of a specific glycosyltransferase (17). This thesis describes the solubilization and partial purification of a e-galactoside a(1-2) fucosyltransferase from porcine submaxillary glands. This enzyme is responsible for the transfer of L-fucose from GDP-fucose to oligosaccharides containing a terminal B-galactoside residue. Partial purification was achieved using the affinity adsorbant GDP-hexanolamine Sepharose. The use of this enzyme in conjunction with a bovine Bfifleacetylglucosaminide 3(1-4) galactosyltransferase and chemically synthesized sugar nucleotides, GDP-fucose and UDP-galactose, enabled the synthesis of quantities of the terminal trisaccharide portion of the blood group 0 antigenic substance sufficient for 13C-nmr evaluation. Enzymatic synthesis of fucosylated disaccharides and trisaccharides containing specific 13C enrichment was accomplished using chemically synthesized UDP-[1-13CJ-galactose and GDP-[1-13CJ-fucose. Specific enrichment with 13C to the 90% level allowed Vicinal carbon-carbon and carbon-hydrogen coupling constants to be evaluated in terms of the conformation of the oligosaccharride. REVIEW OF THE LITERATURE I. Current Concepts in Glycoprotein Biosynthesis The discovery of glycogen synthetase by Leloir and Cardini (18) established the role of sugar nucleotides in complex carbohydrate synthesis as shown below; UDP-Glucose + Glycogen": Glycogen n +1 + UDP Recently attention has turned to the carbohydrate moiety which is covalently attached to either protein or lipid in glycoproteins and glycolipids, respectively. This interest has largely been due to the implication of carbohydrates in many important biological processes (1,2). Complex carbohydrates, in this context, are the oligosaccharide structure found in glycoproteins and glycolipids. The general process for synthesis of complex carbohydrates consists of a transglycosylation reaction as shown below: XDP-O-Rl + Rz-OH -‘_—_§ Rz-O-Rl = XDP where XDP-O-Rl is any number of sugar nucleotides and Rz-OH is the alcohol acceptor, usually a monosaccharide or oligosaccharide. The common sugar nucleotides used in the synthesis of complex carbohydrates are UDP-o-D-glucose, UDP-o-D-galactose, UDP-a-Deflyacetylglucosamine, UDP-o-Nfacetylgalactosamine, GDP-o-D-mannose, GDP-B-L-fucose and CMP-a-sialic acid. The common anomeric linkages found for each of these sugars incorporated into complex carbohydrates are; a and 3 for galactose, Nyacetylgalactosamine and mannose; B for N—acetylglucosamine, and a for fucose and sialic acid (1,2,19). Two types of carbohydrate-protein linkages exist. Carbohydrates linked through asparagine are classified as N-glycosidically linked and those linked through serine or threonine as Ofglycosidically linked carbohydrates. The Neglycosidically linked carbohydrates are found in plasma proteins, hormones, immunoglobulins and enzymes including bovine ribonuclease and al-acid glycoprotein (2). The nglycosidically linked glycoproteins include those from mucous secretions, immunoglobulins, fetuin, plasma membranes and the Antarctic fish freezing-point depression glycoprotein (2). The biosynthesis of N-glycosidically linked carbohydrates has recently been described by Schachter and Roseman (19). These structures share a common core containing mannose and Nfacetylglucosamine. The assembly of this core occurs through a polyiSOprenoid phospholipid acceptor, dolichol phosphate (20). Initiation of the oligosaccharide core occurs by the transfer of Nracetylglucosamine from UDP-GlcNAc to the lipid acceptor (20). The chain is then extended by the sequential transfer of Nyacetylglucosamine and mannose from UDP-GlcNAc and GDP-Man to form Man8(1-4)GlcNAc3(1-4)GlcNAc-P-P-Dol. Further extension occurs with branching by the subsequent addition of mannose and glucose to form mannosylphosphoryl dolichol (19). The entire oligosaccharide is then transferred from dolichol phosphate to an asparagine residue on the nascent glyc0protein. This transfer of the oligosaccharide from dolicohol to the protein occurs in the rough endoplasmic reticulum (19). Further elongation occurs in the Golgi apparatus of the cell. Before the immature glycoprotein reaches the Golgi complex the oligosaccharide is processed to remove all glucose residues and some mannose residues. The processed nascent glycoprotein strucure is shown below: Man o(1-6) Man B(1-4)GlcNAcB(1-4)GlcNAc-AsN-protein Man a(1-3 v Once the nascent glycoprotein reaches the Golgi area final elongation occurs by the sequential action of specific glycosyl transferases (19). The structures of the mature glycoproteins are dictated by the strict substrate specificities of the glycosyltransferases (21). The action of a number of these glycosyltransferases are mutally exclusive (21,22). Vacuoles then bud off from the Golgi apparatus and the mature glycoprotein is transferred to the exterior of the cell. Biosynthesis of Q-glycosidically linked oligosaccharides does not occur by the same mechanism as Neglycosidically linked oligosaccharides (19,23,24). Initiation does not involve pre-assembly of the oligosaccharide as a lipid intermediate (24). The Ser(Thr)-GalNAc linkage is synthesized by a UDP-GalNAc: polypeptide Nfacetylgalactosaminyltransferase (25). Immediately after the incorporation of GalNAc there is a branch point in the synthetic pathway of the oligosaccharide (25). The incorporation of sialic acid a(2-6) to the GalNAc prevents further carbohydrate incorporation and the predominant form of ovine submaxillary mucin results. Incorporation of galactose 8(1-3) to the GalNAc allows further incorporation of carbohydrates to form the common porcine submaxillary mucins. The relative proportions of these two enzymes control this important branch point (26). Additions of carbohydrates to the Gal8(1-3)GalNAc-Ser can then proceed to form the ABO blood group megalosaccharides as shown in Figure (1) (27). .mmuwcmzoommOPmme azocm voopn om< mcp eo weapuchm mpecuaconcmu mpm_qeou on» .HHH .cowuecoaLOUCW mpecuxconceo convene mzoPPe umca oo mo Ecom ucecweoumca on» .H .mmuwcmzuommomwFO nmx:_4 x——euwvwmooxponm mg» mo mmczpuscum .H meam_d H mesmwu AIS 03d Am-Hve _ee Amy AN-HVe eomfleeev-o-onfis_om mcwpcmum mm _umz z m.o .o.m In .mpm_xuooeo 5.68 z: a .6 23%; :2: E 8m e .0 £er 2 m5 .oo .3 662.2388 .533. 2.. mm .m .82 z 35 .3 1e 6:588 5.68. 2:. mm 5.5 .< :3 meet... 2: oe eoeio 2e ass—co H mmocezqmmieoo so mH x m m on nmw_aqm we: mEaNcm .mmocmcqmmuaow seed covp=_m Fonz xm mmoemwmcmchAmooam ANiHve wuwmouompmuiu ucmpw ago—F_xmea:m mcwucoe one eo :o_umu_mwc:e .m mcamwd Hutu/6111) Ulalmd 160 r T T ,J F. ’fl”¢”’ 8 at”... ~~~~-c>-....____ 1. O o) .. O .0 o .— 2.5 Z .. 8 c m o 5 '4': .2, o u. r- 8 Us; a) -—- - a <); «u- . g? i 1 1 a O m N — g o. O. o. O' O O O o---o( |u1/siiun) Ail/010v esmeisuoulfisoong 56 months by dilution with 50% glycerol and storage at -20°. The fucosyltransferase is not stable in low ionic strength buffers and desalting before application to another affinity column or a cation exchange column must be accomplished quickly. Dialysis of large volumes is difficult to accomplish technically and results in loss of enzymatic activity. Desalting was accomplished in 200 ml batches on a 5 X100 cm Sephadex G50 column at a flow rate of 150 ml/hr. Fractions of 20ml were collected. The Sephadex G50 chromatography step completely desalted the fucosyltransferase and resulted in a 3 fold purification, as shown in Figure 4. The enzyme was found to be extremely unstable in low ionic strength buffers, loosing 90% of it's activity in a 24 h period. Concentration of the Sephadex G50 pooled enzyme was achieved by adsorption to a 1 ml column of GDP-Sepharose, in a plastic syringe, at a flow rate of 50 ml/h. The column was washed with buffer and the enzyme eluted with 2 M sodium chloride as shown in Figure 5. Fractions of 1.0 ml were collected and those containing the fucosyltransferase pooled. The pooled enzyme is stable at 4° for at least 2 months. Storage for longer periods of time was best accomplished in 50% glycerol and storage at -20°. IV Synthesis and Purification of Fucosylated Oligosaccharides Fucosylation of galactosylated derivatives was performed at 33° because of the greater stability at this temperature of the GDP-Sepharose II enzyme. Reactions were initially performed with a 2-fold excess of acceptor over the GDP-fucose concentration as described under "Methods". Using the acceptor, Gal3(1-4)GlcNAc-B-hexanolamine, it is possible to fellow 57 .umuowp_ou mew: _E oN mo mcowuoecd .o.o :a .mumpxuoomo Ezwuom ze mN :? umumcnw_w:cm ass—co Amcwev omw xwumgawm so ooH x m a co umppemmu mm; mmeememcecppxmooae ANiavo muwmouompmmim one .mmmcmemcmcp_xmoo:u ANiHvo mu_mopumpmwiu mg» yo mcqummmo use =o_uouwmwcze .e mc:m_d H (3w) eouolonpuoo o g g 8 8 9 8 o .__.(|u1/6u1) ugatmd 9. 9.. 8 I U r a... Q) ‘8: _ 3 2 C Q” .2 i'.’ 3 .8» U L: P ________....—o’" L: VT"— J I L 1 O 8 92 Q 8 o o. - -o (mi/spun) thhgiov esoieisuonpisoong 59 8.5 2 e 2e 82 z e .o :02 2 ON 6.0 In .mumpzuoomo Ezwuom zE mN .m mo.m In .mpm_»uoumo E:_uom z; mN cup: .< ”AA¢ mzoccm ecu um 665mm; use ass—co mmocmcammieow PE H a op noncomum we: mex~cm uoppmmmu use .asamcmopmsocsu NH mmocmgqmmiaoo xm mmecmemcmcu_amoo:d ANiHve mnemouumpmw a mcwucoa one yo cowumcucmucou .m mczm_m 60 H( “Ll/5111) Ulalmd in LO Q" N 93. O. O. O. O. O O O O O o T T j—'__T T m . o- 8 if: .0 i E :3 +0 Z - h- ¢ c a) _____ .0—43 E E; """"" o 1:: fr»— ————— ——— E (De-- L‘- - a . <1- 5 ‘1 O 1 1 1 1 L (I) (.0 N 91- 9- O. o. 3. O. O O O O O O O o. “cum/spun) lip/111w esmelsuonpisoong 61 the kinetics of the reaction and estimate GDP-fucose hydrolysis, as described under “Methods". Under these conditions, 94% utilization of GDP-fucose could be achieved with 72% incorporated into product and 22% hydrolysis to fucose, as shown in Figure 6. Large scale reactions with 13C-enriched acceptors were performed using a 1:1.2 ratio of GDP-fucose to acceptor. The reaction profile, for the synthesis of Fuc6(1-2)[1-13C]Gal8(1-4)GlcNAc followed by high pressure liquid chromatography, as described in "Methods", is shown in Figure 7. No unreacted GDP-fucose is detected in the reaction mixture after 20 h, Figure 7C, the only products observable are GMP and GDP. The yield of Fuc6(1—2)[1-13C]Gal8(1—4)GlcNAc was 83% based on starting GDP-fucose. Hydrolysis of GDP-fucose to fucose was approximately 20% in all reactions, independent of acceptor concentration. The factors influencing hydrolysis of GDP-fucose were further investigated by determining the kinetics of hydrolysis in the absence of acceptor and in the absence of enzyme, as shown in figure 8. The hydrolysis of GDP-fucose by the enyzme preparation in the absence of acceptor indicates that the fUcosyltransferase might act as a phosphohydrolase. Purification of the large scale fucosylation reactions is easily achieved by deproteinization, deionization and gel filtration. Several methods for removal of proteins were investigated. Deproteinization with barium hydroxide and zinc sulfate by the method of Somogyi (107) gave a white precipitate of barium sulfate and protein which was difficult to filter and gave in large volumes of filtrate containing the product. Alternatively, products containing a primary amino group could be adsorbed to a small Dowex 50 (hydrogen) column and eluted with 1 M .ooNHHocox; omooaeioow Ho “cacao ecu mucomocooe :Hmoc H xozoo oco om xoZoa goon m:H=_oucoo csaHoo on» .2 soc» mcwszo xHH>HHoooHooa .ooNHHoLoH: omooowioow mo “cacao asp oco o:HEoHo=oxo;1mioHpoooHUom .HH_>_poooHooc co» ooucaoo oco emoogpoz= Loon: ooQHLomoo mo oops—o moo: mcszHoo :pom .:_moe HooHLonov H xozoo oco Hammocoxgv om xozoa zuoo mchwopcoo esoHoo HoQHQ Lampoon o op omHHooo poooHHo ocooom ocu oco HooHLoHcov H xozoo Ho can—cu pooHo cooumoo m on ooHHooo mo; HoaoHHo oco .couoz cup; :oHuoHHo an oouo:_ELop oco om>oeog mom; muooo_Ho oz» .moeHu poocoemHo H< .cowpoozocw mo moEHH m=HHgo> Ho mcoHuoooc mcwxommo Ho oocouwcos mo: pooooco Ho :oHpoELow mo own; one .omocoemcocpmeoood HNiHvo oonouooHow m ocwocoo on» ssz o:HEoHocoxozim1oHHuoomoc .:HE «N oco NH.N mew; new use omoooHiooo .ezu com moswp :oHHcopom .HHo>HHooomoL .coHuonoo:_ Ho ;ON oco H.o op ocoomoccoo .0 use .m .< mosogm mmHHHoco oer owes“ one .:E=Hoo xoeoc Ho noxommo mom: muoooHH< .acoocmouoeoccu oHooHH mcommoco gmHI Hm ooonHod oHuoooHooL co+ oopcsoo mo: ouoaHo one .oazHoo HooHLoHcov H xozoo o ow :oHHooHHooo oco .emooguoze :H ooowcomoo HHmooH>oco .ocopxwe :oHHoooocH ogu soc» muoooHHo mcH>oeoL an oocomome mew: omocommcoLHmeooae ogu Ho .HOIIJQV copooooo Ho wocomao asp cw .mHmHHoLox; omoozeieoo wo mopom .mpocumnam eopoooo< c< Ho oucomo< one cH omocoemcocpmeoozd HNiHVo oonouooHowim och Hm mmooomioaw mo mHmHHocoH: Ho moHHo:_¥ .w meomwd 67 m mczmwm 2: 22:. cozooom 8 8 -9 oo 8 0 v- 0 (D 8 c3 (0 0le P32901994 Wild-dos) IO Uouomg epw 68 pyridinium acetate. Removal of the pyridinium acetate by rotatory evaporation at 30° resulted in slightly acidic conditions that led to some fucose hydrolysis. However, purification of the disaccharide, Gal 8(1-4)GlcNAc-B-hexanolamine from the galactosyltransferase reaction, with Dowex 50 (hydrogen) chromatography did not result in any detectable hydrolysis of the product. The best method for removal of proteins from the fucosylation reaction was concentration by Amicon filtration. After washing the concentration cell several times, the product was recovered quantitatively in the filtrate free of proteins. Deionization and removal of GMP, GDP and GDP-fucose was achieved by passing the filtrate through a 1 X 4 cm column containing Dowex 1 (chloride) and Chelex 100 (sodium). The solution was then concentrated to 2 ml and applied to a 4 X 90 cm gel filtration column containing Bio-Gel P2 (-400 mesh) equilibrated in 0.1 M triethylammonium bicarbonate pH 7.5. A typical separation profile, for the fucosylated and unreacted acceptor is shown, in Figure 9, for FuCo(1-2)Gal~8-hexanolamine. A two fbld excess of acceptor was used in the reaction incubation. The fucose containing disaccharide eluted first containing [UL-14CJ-L-fucose glycosidically linked to the galactose residue. The primary amino group of the hexanolamine, present in both FuCo(1-2)Gal-8-hexanolamine and Gal-B-hexanolamine, was quantitatively measured using a fluorescent assay for primary amines (95). Removal of the triethylammonium bicarbonate buffer by rotatory evaporation yielded the fucosylated product ready for nmr analysis. Fucosylated compounds synthesized with the e galactoside a(1-2)fucosyltransferase were; Fuc 0(1-2) Gal3(1-4)GlcNAc-B-hexanolamine, FUCa(1—2)Gal-3-hexanolamine, FUCO(1-2) 69 .omocoemcocpHHmooze HNiHVo oonouooHomim 6:» Ho omooom mooHinzuioow Eoce omccommcocu mo; m:_EoHocoxo;1m1Hoo HNiHvo one .oUHLogooomHo ogp :H Hommoco omooowinimueH142H one .emoocuoze cH ooowcomoo mo .xommo HcoomocooHe o m:_m: cocomoms mo: zoom—mo ozHEoHocoxo; ox» cw ooocm o:_Eo AcoeHco och .m.N Io .opoconcooHo EzwcoEEonzumHLH z H.o cH oouoanHwooo csoHou Acmos oooiv No Hooiowm o :o coacomcoo mo; coHuocpHHm How .cowpocuHHN How an o:_soHocoxozim1How oco o:Ham—ocoxozimiHooHNiHvoood we :oHHocooom .m ocsde 70 o__ _o (mu 91.7) UO!SS!UJ3 GOUSOSSJOmd o 0 o Q Q 8 8 st 8 0 IT I T I 1 r (:> to - a ______ -_Lmo .m:m_wmpazum5mguwu mo upmwmczou Egg m.¢oH um macmcommg cu venom mw paw Po mzp .m:FEw_o:mxmzuuno wwwzm _ouweo;u m on mocmgmmmg saw: Eng cw cm>pm men mpmwsm Pmo_sm;o .m 5 7 ¢.~m w.Hm o.- ~.H~ m.HN mewsmpocmxm: mo Po m.om m.m~ m.m~ m.m~ m.m~ m.m~ m.m~ _»»aoa-z co _acume oNH aka ~.mua m.m~H N.©~H m.m~H qumumuz do meoagmu w.oH ¢.~H m.mH m.oH N.NH ~.~H as; “.mm m.mc m.mm m.mm o.Ho m.~o m.mo m.~o m.~o Paw o.Ho o.Ho m.Hc m.Ho m.Ho m.Ho «.mm N.~o o.~o uwgmu mo upsmmg a mo Agaa v.w~ op «.mn eogmv cpm_w=zou umuwwcm m? me.~u use .x_m>_uumammg .ozm ucm —mw we _u on ucoammggoo sag m.HoH vac m.moH an ucaoe mmucmcommg o3» mch .m:_5aPo=axaz-m-awm mgm mmucmcommg mg» we “cchm_mmm mumeEoo .u_u ma :mo Eaguomam ugh .m—QEMm mg» cw xuwgaaew cm .mc_Em_ocmxm:umuowuumammg .u_:cmc: m_ Paw Nu och .w_nm>gmmao uoc mew muwgmgoummwu use we mcongmo oucmucznm chsgmz .m:Pam_o=mxm;-muump wom mg» op umsowgcm m? Paw Po mgp .m:Pam—ocmxmzuuuu_pomnmme ...Fu use .—u ._o cmpmam_ wee owpomamme .m:_e use one ou pomamme new: Pmo No mo cowuwmoa on» wee ace; Poo msu one _u yo cowp_moq mcu waveommu mmrmcm a use i one .Pmoflmifivoozm cH ecom owuwmoox—u vc< s .mmpm:< A_meum;wuv chovmeop oz» 05H mcenweommo m:o_uumwoea cmszmz .HN mesm_m 111 ‘3' H2 Figure 21 112 coupling (117). Coupling constants in the range of 3.7 to 5.5 Hz were observed in all cases (117). The 5.5 Hz coupling constant in B-cellulose octaacetate was related to the 15.7° angle determined by X-ray crystallography and the conclusion drawn that the urconformation was the same in solution as in the crystalline state (117). The value of the J3 coupling constant was noted to be remarkabely constant regardless of the (1-3) or (1-4) linkage in these disaccharides (117). Nunez and Barker (13) were the first to use 3d C-C inter—residue coupling to evaluate the w torsion angle in the glycosidic linkage, Gal B(1-4)GlcNAc-B-hexanolamine. Carbon-13 enrichment to the 90% level at Cl allowed evaluation of 3a coupling from CT to C3' and Cl to C5'. A coupling constant could not be observed to either C3' or C5' of the GlcNAc residue (13). However, C5' GlcNAc was shown to be broadened by > 1 Hz with respect to other singlets in the spectrum (13). This was interpreted as indicating a 3a C1-C5.5 1.5 Hz and a 3J C1-C3' = 0 Hz (13). Since a series of model compounds with defined m torsion angles for an observed coupling constant are not available the value of the coupling constant was compared to intra ring 3J(>{;coupling constants and dihedral angles in monosaccharides. Walker §£.El- (68) observed a 3d C1-C6 intra ring coupling of 3.7 Hz in hexopyranosides in which C1 and C6 are trans. A 30 C1-C4 coupling, corresponding to a dihedral angle in which C1 and C4 are gauche, was not observed in any of the aldopyranoses (68). A 3d C1-C6 of 0 to 2.6 Hz (110 to 140°) for pentofuranoses, pentofuranosides and 1,4 aldonolactones has also been observed by Nunez, (personal communication). Using this data to establish limits for 113 31>4: coupling in carbohydrates a conformer which favored C1 Gal at an angle slightly greater than 120° with respect to C5' GlcNAc and slightly less than 120° with respect to C3' GlcNAc was postulated (13). This conformation, shown in Figure 22, was also proposed by X-ray crystallography (121) and theoretical calculations (122) for lactose and cellobiose which have the same 3(1-4) glycosidic linkage as Gal3(1-4)GlcNAc-B-hexanolamine (13). To obtain an approximation of the solution value for the 0 torsion angle, Nunez and Barker (13), relied on 2d C1-0-C4' coupling constants through the glycosidic linkage. Geminal, ZJC-O-C , coupling through the ring oxygen was found to be influenced by the configuration of the C, 0 and H substituents on the carbon involved in the coupling (123). Both a ring oxygen and a ring carbon are considered to contribute equally to the coupling. An oxygen or carbon gauche to the coupled carbon is considered to make a negative contribution to the coupling whereas an oxygen or carbon anti_to the coupled carbon makes a positive contribution to the coupling (68). Coupling, 20 1301-04'» from [1-13c] Gal to C4' GlcNAc was not observed in the disaccharide Gal3(1-4)GlcNAc-3-hexanolamine (13). However, a linebroadening of approximately 1 Hz was observed indicating an interaction between 13Cl Gal and C4' GlcNAc (13). Two possible 0 torision angles would result in a small 20 C1-C4' coupling constant. The rotamer that was favored had C4' bisecting 05 and HlGal again in agreement with the exo-anomeric effect (119) and X-ray data on lactose and cellobiose (121). Fucosylation of [1-1301 Gal3(1-4)GlcNAc-B-hexanolamine allowed the conformations about the angles 0 and 0 in the Gal3(1-4)GlcNAc 114 .3: mcEmPocmxmzrmio4: coupling in rotamers C and 0 would be expected to lie in the range of 0 to > 1.0 Hz for gauche situated carbons since 3J C1-C4 in aldopyranoses, C1 gauche to C4, is not observable (68). A conformation with Cl Fuc less than 120° to Cl Gal would not be expected to result in a 3 Hz linebroadening since C3'GlcNAc is less than 120° to Cl'Gal in the disaccharide Gal3(1-4)GlcNAc B-hexanolamine and no increased linebroadening was observed (13). The observed 30 Cl-Cl' interaction of a 3 Hz linebroadening, approximately a 1.5 Hz coupling, favors a m torsion angle with Cl at an angle Slightly greater than eclipsed with H2' Gal (Figure 23 Rotomer A). NMR can not distinguish between a rotamer with Cl Fuc at an angle slightly greater than 120° (Figure 24 Rotomer A) from C1' Gal and a conformer with Cl turned through 180° as Shown in Figure 24; Rotomer 8. Model building studies do not completely resolve this ambiguity. Steric interactions appear greater in rotamer B where the fucopyranosyl ring interferes with the Nfacetylglucosamine ring and the Cl Fuc is nearly eclipsed with Cl Gal. Results obtained from model building of the O antigenic trisaccharide and conclusions from theoretical calculations (122) X-ray crystallography (121) and nmr (13,117,118) on the 0 angle in other 123 .03; F0 uc< Few Pu cmmZumm mew—asoo pmcwor> N: m.H < »_wueaexocqa< m>wu OP umuuwaxm mmmxcwe uwuwmouapo Pmoamravduzu mg» uson< mm_mc< _mcome0P .em meamwm 124 CI H2 ca’ Cl’ CI B ‘ Figure 24 125 disaccharides favor the rotomer (A) in which Cl Fuc is at an angle slightly greater than 120° with respect to Cl Gal. The 0 torsion angle about the Fuc6(1-2)Gal glycosidic linkage was evaluated using the disaccharide FUCa(1-2)Gal-B-ethyl. Ethyl B-D-[2-13CJ-galactopyranoside was chemically synthesized and fucose added to it enzymatically with the use of GDP-fucose and the B-galactoside 0(1-2) fucosyltransferase. The carbon-13 enriched and natural abundance FUCa(1-2)Gal-B-ethyl were used as a model for the blood group 0 trisaccharide. Evaluation of the 0 torsion angle could be obtained by 3d 13C2'-HI coupling. There is ample experimental and theoretical evidence that a "Karplus-type" of relationship exists between 3a C-H coupling and the torsional angle (56). Homer gt al. (125) have established a "Karplus-type" of relationship involving inter-residue Sp3 carbons contained in the specific sequence, 13C-0-C-'H. The region of 0 to 60° was difficult to define precisely due to the lack of appropriate model compounds (125). The 180 MHz 'H nmr of FUCa(1-2)Gal-B-ethyl was obtained and the Hl Fuc examined (shown in Figure 20A). The anomeric proton of fucose resonates as a doublet at 5.04 ppm aS a result of a 3.4 Hz 3a Hl-H2 coupling. No long range coupling was observed. The Hl Fuc resonance was confirmed by comparison with the 'H nmr of [1-13C]FUCa(1-2)Gal-B-ethyl. The Hl of Fuc in FuCa(1-2)[2-13c]Gal-p-ethyl is a multiplet (shown in Figure 20B) resulting from 3d H1-H2 and 3d H1_13C2u coupling. The multiplet is comprised of a 3d H1-H2 Splitting of 3.4 Hz and a 3d H1-13C2' splitting of approximately 126 3.2 Hz. The inter-residue coupling of 3.2 Hz corresponds to a torsional angle in which C2'Gal is sygfclinal to 05 and Hl. NMR can not distinguish between this conformer and one turned through a 180°. However, a conformer turned through 180°, having C2' syfleclinal to C2 and 05 is sterically unfavorable as discussed previously (124). Interestingly, the former angle corresponds closely to the 0 torsion angle in gentabiose (glucosee(1-6)glucose) octaacetate (3.1 13C6-H1 of 3.8 Hz) (118). Two bond, 013C1_C4, , in Galp(1-4)GlcNAc also indicated a 0 torsion angle with C4' near syn-clinal with HI and 05 as was observed in the crystalline structure of stereo-Similar lactose (13). Lemieux and co-workers (129) estimated 0 for a and 3 alkyl-D-glycopyranosides and found 3a C-H values of approximately 3.8 and 4.2 Hz for the a and 8 anomers, respectively. The exo-anomeric effect appears to be the predominant force in stabilizing the conformation about the 0 torsion angle in the absence of extenuating circumstances. Small variations observed in the 0 angle may be the result of steric interactions, intramolecular hydrogen bonding and a verses 8 glycosidic linkage effects. Enzyme mediated synthesis of complex oligosaccharides, using partially purified glycosyltransferases and chemical synthesized sugar nucleotides, has been shown to proceed with high yield, anomeric purity and ease of product purification. The galactosyltransferase and the fucosyltransferase have been shown to utilize acceptor substances containing a number of different aglycons. Partial purification of these enzymes using affinity adsorbants allows quantities of enzyme to be easily prepared in less than two weeks. 127 Sugar nucleotides may be synthesized from specifically l3C-enriched carbohydrates and used with the glycosyltransferases to synthesize specifically 13c-enriched complex oligosaccharides. High resolution 13C-nmr allows product characterization and unambiguous assignment of many resonances with the use of specific 13c-enrichment. Accurate resonance assignment is the first priority before using the synthesized oligosaccharide in biological studies and for future assignment of more complex biological oligosaccharides. Specifically 13C-enriched compounds allow the measurement of inter-residue 3d C-C' 20 C-C and 3J C-H coupling constants which can then be used to evaluate the solution conformation of the molecule. The specifically 13C-enriched fucosylated compounds can now be used in biological studies to evaluate glycoside-protein interactions, in particular antigen-antibody interactions. Glycoproteins and glycolipids could also be used as acceptors for the glycosyltransferases allowing specific 13C-enrichment of the carbohydrate moiety in the glycoprotein or glycolipid. Examination of these specifically 13c-enriched glycoproteins and glycolipids may provide much information as to the role of carbohydrates in these molecules. 1. 2. 3. 4. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. BIBLIOGRAPHY Nalborg, Jr., E.F. Glycoproteins and Glycolipids in Disease Processes A.C.S. Symposium Series 99, (l978). Spiro, R.G. Advan. Protein Chem. 91, 349 (l973). Marcu, D.M. New Eng. J. Med. 999, 994 (1969). Lemieux, R.U. and Driguey, H., J. Am. Chem. Soc. 91, 4009 (1975). Lemieux, R.U. and Driguey, H., J. Am. Chem. Soc. 91, 4063 (l975). Bundle, D.R., Smith, I.C.P. and Jerning, H.J., J. Biol. Chem. 999, 2275 (l974). Harris, P.L. and Thornton, E.R., J. Am. Chem. Soc. 999, 6738 l978 . Czarniecki, M.F. and Thornton, E.R., J. Am. Chem. Soc. 99, 8279 l977 . Mazueek, M. and Gorin, P.A.J., Carb. Res. 19, Cl (l979). Brewer, C.F. and Keiser, H., Proc Nat. Acad. Sci. U.S.A. lg, 3421 (l975). Villagranca, J.R., Arch. Biochem. Biophys. 199, 465 (l974). Colson, P., Jennings, H.J. and Smith I.C.P., J. Am. Chem. Soc. 99, 8081 (1974). Nunez, H.A. and Barker, J. Biochem. (in press) l980. Brew, K., Vanaman, T.C., Hill, R.L., Proc. Nat. Acad. Sci. U.S.A. 59, 491 (l968). Barker, R., Olsen, K.N., Shaper, J.H., and Hill, R.L., J. Biol. Chem. 251. 7135 (l972). Bean, R.C. and Hassid, H.Z., J. Am. Chem. Soc. 11, 5737 (l955). Kabat, E.A. Blood Group Stubstances; Their Chemistry and Immunochemistry. New York: Academic Press (T956). Lelori, L.F. and Cardini, C.E., J. Am. Chem. Soc. 19, 6340 (1957). Schachter, H. and Roseman S: Mammalian Glycosyltransferases: Their Role in the Synthesis and Funtion of Glycoproteins. In Biochemistry of Proteoglycans and Glycoproteins, (H.J. Lennarz, Ed), (in press). 128 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 129 Haechter, C.J. and Lennarz, H.J., Ann. Rev. Biochem. 99, 95 (l976). Beyer, T.A., Rearick, J.I., Paulson, J.L. Prieels, J.P. Sadler, J.E. and Hill R.L., J. Biol. Chem; 254, 12531 (l979). Paulson, J.C. Prieels, J.P. Glasgow:_[.R., and Hill, R.L., J. Biol. Chem. 999, 5617 (l978). Young, J.D., Tsuchiya, 0., Sandlin, D.E. and Holroyde, M., Fed. Proc. 99, 1684 (l978). Schachter, H., Narasimhan, S. and Wilson, J.R. Biosynthesis and Catabolism of Glycoproteins. In Glycoproteins and Glycolipids in Disease Processes. ACS Symposium Series (Washington l978). Hill, H.D. Jr., Schwyzer, M., Steinman, H.M. and Hill R.L., J. Biol. Chem. 999, 3799 (l977). Schachter, H., McGuire, E.J. and Roseman, 5., J. Biol. Chem. 999, 5321 (l971). Feizi, T., Kabat, E.A. Vicari, G., Anderson, B. and Marsh, w.L., J. Immunol. 999, 1578 (1971). Brah, B., Schiff, F. and Neinman, H. Klin. Hachenschr._99, 1592 (1932). Hakomor, S, Chem. Phys. Lipids, 9, 96 (l970). Schwyzer, M. and Hill, R.L., J. Biol. Chem. 999, 2338 (l977). Schwyzer, M. and Hill, R.L., J. Biol. Chem. 999, 2346 (1977). McGuire, E.J., Jordian, G.N., Carlson, D.M., and Roseman, S., J. Biol. Chem. 999, 4112 (1965). Turkington, R.U., Brew, K. Vanaman, T.C. and Hill R.L., J. Biol. Chem. 999 (1978) 3382. , Palmiter, R.D., Biochem. J. 999, 409 (l969). Vanderhaar, B., Owens, 1.5., and Topper, Y.J., J. Biol. Chem. 999, 467 (l973). Turkington, R.w. and Hill R.L., Science 999, 1458 (I969). Sacke, R.G. and Heald, C.w. In Lactation A Comprehensive Treatise, Academic Press, New York, 2, 147 (l974). Powell, J.T. and Brew, K., Eur. J. Biochem. 99, 217 (l974). Mageei E.E. Mawal, R., and Ebner, K.E., J. Biol. Chem. 999, 7565 (l973 . 40. 41. 42. 43. 44. 45. 46. 47. 48. 49. 50. 51. 52. 53. 54. 55. 56. 57. 58. 59. 60. 61. 62. 130 Heath, E.C., Ann. Rev. Biochem. 99, 29 (1971). Watkins, W.M. and Hassid, W.Z., J. Biol. Chem. 999, 1432 (l962). Broadbeck, N. and Ebner, K.E., J. Biol. Chem. 999, 762 (1966). Babad, H. and Hassid, W.Z., J. B101. Chem. 999, 2672 (1966). Trayer, I.P. and Hill, R.L., J. Biol. Chem. 999, 6666 (l971). Porath, J., Axen, R. and Ernback, 5., Nature 999, I496 (l967). Bell, J.E., Beyer, T.A. and Hill, R.L., J. Biol. Chem. 999, 3003 (1976). Chester, M.A. and Watkins, W.M., Biochem. Biophys. Res. Com. 99, 835 (1969). Munro; J.R. and Schachter, H., Arch. Biochem. Biophys. 999, 534 l969 . Baenziger, J. Kornfeld, S. and Kochwa, S., J. Biol. Chem. 999, 1897 (l974). Baenziger, J. and Kornfeld, S. J. Biol. Chem. 999, 7270 (1974). Kornfeld, R., Keller, J. Baenziger, J. and Korneled, S., J. Biol. Chem. 999, 3259 (l971). Jarkovsky, A., Marcus, D.M., Grullman, A.P., Biochem. 9, 1123 (1970). Grollman, A.P., Hall, C.W. and Ginsburg, V., J. Biol. Chem. 999, 975 (l965). Schenkel-Brunner, H., Chester, M.A. and Watkins, W.M., Eur. J. Biochem. 99, 269 (l9720. Pacuszka, T. and Koscielak, J., FEBS Letters 99, 348 (l974). Bella, A. and Kim, Y.S., Arch. Biochem. Biophys. 999, 753 (1971). Jabbal, I. and Schachter, H., J. Biol. Chem. 999, 5154 (l971). Basu, S., Basu, M. and Chien, J., J. Biol. Chem. 999, 2956 (1975). Hoflack, R. and Verbert, A., Eur. J. Biochem. 99, 1 (l978). Basu, M. Moskal, J., Gardner, 0. and Basu, 5., Biochem. Biophys. Res. Commun. 99, 1380 (l975). Aminoff, D. and Furnkawa, K., J. Biol. Chem. 999, 1659 (l970). Stealey, J.R., Watkin, W.M., Biochem. J. 999, 160 (l971). 63. 64. 65. 66. 67. 68. 69. 70. 71. 72. 73. 74. 75. 76. 77. 78. 79. 80. 81. 82. 83. 131 Chester, M.A., Yates, A.D., and Watkins, W.M., Eur. J. Biochem. 99, 583 (l976). Annison, E.F. and Morgan, W.T., Biochem. J. 99, 247 (l952). Kosielak, J., Biochem. Biophys. Acta. 99, 313 (l963). Shen, L., Grollman, E.F. and Ginsburg, V., Biochem. 99, 224 (l968). Bosmann, H.B., Hagopian, A. and Eylar, E.H., Arch. Biochem. Biophys. _1_2_8. 240 (1968). Walker, T.E., London, R.E., Whaley, T.W., Barker, R. and Matwiyoff, N.A., J. Am. Chem. Soc. 99, 5807 (l976). Gagnaire, D.Y., Nardin, R., Taravel, F.R. and Vignon, M.R., Nouveau J. Chim. 9, 423 (l977). Bundle, 0.R., Jennings, H.J., and Smith, I.C.P., Can. J. Chem. 99, 3812 (l973). Pfeffer, P.E., Valentine, K.M. and Parrish, F.W., J. Am. Chem. Soc. 999, 1265 (1979). Gorin, P.A.J. and Mazurek, M., Carbhydr. Res. 99, 171 (I976). Bock, K., Lundt, I. and Pedersen, C. Tetrahedron lett. 99, 1037 (l973). Bock, K. and Pedersen, C., Acta Chem. Scand., Ser. B, 99, 258 (1975). Perlin, A.S. and Casu, B., Tetrahedron Lett. 99, 2921 (1969) Schwarcz, J.A. and Perlin, A.S., Can. J. Chem. 99, 3667 (I972). Schwarcz, J.A., Cyr, N., Perlin, A.S., Can. J. Chem. 99, 1872 (l975). Karplus, M., J. Chem. Phys. 99, 11 (1959). Karplus, M., J. Am. Chem. Soc. 99, 2870 (l963). Wasylishen, R. and Schaefer, T., Can J. Chem. 99, 2710 (l972). Karabatsos, G.J., Orzech, Jr., C.E. and Hsi, H., J. Am. Chem. Soc. 99, 1817 (l966). Weigert, F.J. and Roberts, J.D., J. Am. Chem. Soc. 99, 5962 (1967). Karabatsos, G.J., Graham, J.D., and Vane, F.M., J. Am. Chem. Soc. 99, 37 (1962). 84. 85. 86. 87. 88. 89. 90. 91. 92. 93. 94. 95. 96. 97. 98. 99. 100. 101. 102. 103. 104. 132 Marshall, J.L., Miller, D.E., Conn, S.A., Seiwell, R., and Ihrig, A.M., Acc. Chem. Res. 9, 333 (1974). Hansen, P.E., Org. Mag. Res. 99, 215 (1978). Wray, V., Prog. in NMR Spectroscopy 99, 177 (1979). Stothers, J.B., Carbon-13 NMR §pectroscopy, Academic Press, New York (1972). Weigert, F.S. and Roberts, J.D., J. Am. Chem. Soc. 99, 6021 (1972). Marshall, J.L. and Miller, D.E., J. Am. Chem. Soc. 99, 8305 (1973). Barfield, M., Burfitt, I., and Doddrell, 0., J. Am. Chem. Soc. .99, 2631 (1975). Barfield, M., .1. Am. Chem. Soc. 909, 1 (1980). Hirao, K., Nakatsuji, H. and Kato, H., J. Am. Chem. Soc. 99, 31 (1973). Bandursky, R.A. and Axelrod, B., J. Biol. Chem. 999, 405 (1953). Levy, A.L. and Chung, 0., Anal. Chem. 99, 896 (1953). Bohlen, P., Stein, 5., Dairman, W., and Undenfriend, 3., Arch. Biochem. and Biophys. 999, 213 (I973). Moffatt, J.G., In Methods in Enzymology.9, Academic Press, New York, 136 (1966). Cuatrecasas, P., J. Biol. Chem. 999, 3059 (1970). Bates, Frederick and Associates, In Polarimetry, Saccharimetry and the Sugars, U.S. Government Priniting Office, 488 (1942). MacDonald, D., J. Org. Chem. 99, 1107 (1962). Nunez, H.A., O'Connor, J., Rosevear, F.R. and Barker, R., submitted to Can. J. Chem. (1980). Horton, 0., Org. Syn. 99, 1 (1966). Chiang, C.K., McAndrew, M. and Barker, R., Carb. Res. 99, 93 (1979). Isbell, H.S., Methods of Carbohydr. Chem. 9, 13 (1963). Fletcher, Jr., H.G., Methods Carbohydr. Chem. 9, 77 (1962). 105. 106. 107. 108. 109. 110. 111. 112. 113. 114. 115. 116. 117. 118. 119. 120. 121. 122. 123. 124. 133 Serianni, A.S., Nunez, H.A., and Barker, R., Carbohydr. Res. 99, 71 (1979) Sadler, J.E., Rearick, J.I., Paulson, J.L. and Hill, R.L., J. Biol. Chem. 999, 4434 (1979). Somogyi, M., J. Biol. Chem. 999, 69 (I945). Kamath, S.A. and Rubin, E., Biochem. Biophys. Res. Commun. 99, 52 (1972). Koenigs, W. and Knorr, E. Ber. 99, 957 (1901). Wulf, G. and Rohle, G., Angew, Chem. Int. Ed. Engl. 99, 173 (1974). Lemieux, R.U., Hendriks, K.B., Stick, R.V., and James, K., J. Am. Chem. Soc. 99, 4056 (1975). Sinay, P., Pure and Appl. Chem. 99, 1437 (1978). Dorman, D.E., Angyal, S.J. and Roberts, J.D., J. Am. Chem. Soc. 99, 1351 (1970). Dorman, D.E., and Roberts, J.D., J. Am. Chem. Soc. 99, 1355 (1970). Usui, T., Yamaoka, N., Matsuda, K. and Tuzimura, K., J. Chem. Soc. Perkin I, 2425 (1973). Gagnagre, 0. and Vincendon, M., J. Chem. Soc. Chem. Comm. 99, 509 1977 . Excoffier, G., Gagnaire, D.Y., and Taravel, F.R., Carbhydr. Res. 99, 229 (1977). Gagnaire, D.Y. Nardin, R., Taravel, F.R., and Vignon, M.R., Nouyeau, J., Nouveau, J. De Chim 9, 5 (1977). Lemieux, R.U., and Koto, S., Tetrahedron 99, 1933 (1974). Booth, H., Progr Nucl. Magn. Resonance Spectrosc. 9, 149 (1969). Marchessault, R.H. and Sundararajan, P.R. Pure and Applied Chem. 99, 399 (1975). Rees, D.A. and Smith P.J.C., J. Chem. Soc. Perkin II, 836 (1975). Bock, K. and Pedersen, C., Acta Chem. Scand. 999, 354 (1977). Lemieux, R.U., Koto, S. and Voisin, 0., In Anomeric Effect Origjn and Consgguences (W.A. Szarek and D. Horton Ed). ACS Symposium Series, 99, 17 (1979). 134 125. Hamer, C.K., Balza, F., Cyr, N. and Perlin, A.S., Can. J. Chem. 99, 3109 (1978). 126. DeBruyn, Anteunis, M., Garegg, P.J. and Norbert, T., Acta. Chemica. Scand. 999, 820 (1976). 127. Hirotsu, K. and Shimada, A., Bull. Chem. Soc. Jap. 99, 1872 (1974). 135 APPENDIX List of Publications Rosevear, P., VanAken, T., Baxter, J., and Ferguson-Miller, S: Alkyl Glycoside Detergents: A Simpler Synthesis and Their Effects on the Kinetic and Physical Properties of Cytochrome g Oxidase (in press Biochemistry). Nunez, H.A., O'Connor, J.V., Rosevear, P.R., and Barker, R.: The Chemical Sythesis and Characterization of a- and 8-L-Fucopyranosyl Phosphates and GDP-Fucose (submitted to Can. J. Biochem.) Rosevear, P.R., Murphy, K., and Barker, R.: Evaluation of the Mechanism of the Alkaline Degradation of Glucose Using Isotopically Enriched SubstrateszThe Retention of Hydrogen from C2 of Glucose (submitted to J. Am. Chem. Soc.) Rosevear, P.R. and Barker, R.: Synthesis and 13c NMR Analysis of 1-13C Enriched L-Fucose and L-Rhamnose (in preparation for Carbhydr. Res.)